Sign in
TerminatedNo phase

Smoking Cessation Support for Patients With Rheumatologic Diseases Via WhatsApp

Key facts

Who runs it
Recep Tayyip Erdogan University Training and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
220 people enrolled
Started
10 Nov 2023
Ended
30 Jun 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mobile messages via What's App
Record updated
25 July 2025
Why it stopped
Enough participants included to the study.

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Patients applying to the rheumatology outpatient clinic
  • Those aged 18 and over
  • Those who are active smokers
  • Those diagnosed with inflammatory rheumatic disease
  • Those who gave informed written consent to participate in the study

Who cannot take part

  • Those with active psychiatric disease diagnoses such as psychosis, major depression, schizophrenia among their current diagnoses
  • Those with cognitive dysfunction

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Smoking cessation support for patients with rheumatologist diseases is an underestimated issue. In the previous prospective cohort study the investigators determined that with the brief cessation interventions 63.5% of smokers with rheumatologic diseases were willing to quit and the rest 36.4% were not willing. Among the willing group the highest quit rate was detected in the group that admitted to smoking cessation clinic. Therefore to increase the willingness to quit as well as to increase the Access to evidence based tobacco cessation support using new comminication technologies can be relevant. Investigators' aim in this study is to examine the effect of including WhatsApp in the routine smoking cessation practices on the quitting success of active smokers with rheumatic diseases who apply to the Rheumatology outpatient clinic.

The 2 groups in the trial

  • Usual careExisting treatment, for comparison

    Usual care arm, smoker patients with rheumatologist diseases will be implemented brief smoking cessation interventions and referred to quit lines or smoking cessation services and also directly contacted to get an appointment from the cessation clinic.

    Treatment: Mobile messages via What's App

  • InterventionTreatment being tested

    The intervention arm, smoker patients with rheumatologist diseases will be implemented brief tobacco cessation interventions and directly contacted to get an appointment from cessation clinic and will be send periodically motivational and informative text messages regarding tobacco cessation via WhatsApp.

    Treatment: Mobile messages via What's App

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Supporting Routine Smoking Cessation Interventions With Whatsapp-mediated Motivational Information on Smoking Cessation Success in Active Smokers With Inflammatory Rheumatic Diseases: A Randomized Controlled Study
Record updated
25 July 2025